UBS is appointing Steven Meehan as CEO of its Russia and CIS operations effective from March 2008.
Meehan will report to Alex Wilmot-Sitwell, chairman and CEO, UBS Group EMEA and global head, Investment Banking Department, UBS Investment Bank.
Currently Managing Director in UBS’s Global Healthcare Group and Head of Life Sciences, based in New York, Meehan has over 20 years’ experience in the investment banking industry. Prior to joining UBS in 1999, Meehan worked for Salomon Smith Barney where he was a senior director for their environmental and medical device group.
Previously he worked for NatWest Securities in New York, London and Switzerland where he was jointly responsible for building an investment banking presence in the US.
In his new role, Meehan will be responsible for all of UBS’s Russia/CIS businesses, focusing on the continued expansion of UBS’s successful platform in the region. As part of this, he will continue with the integration of all of our businesses in Russia/CIS as well as the further development of cross-business opportunities to maximise revenue growth and profitability.
“I am delighted that Steven has agreed to take on this key role. He has a strong track-record of building and growing successful businesses and will be instrumental in driving forward our integrated platform in Russia/CIS and boosting our leading position in this fast growing region. I would also like to take this opportunity to thank Ed for his contribution to the firm over the last 10 years and wish him all the best for the future,” says Wilmot-Sitwell.
Steven succeeds Ed Nicholson who has decided to retire after 10 years with UBS to pursue other interests outside of banking.